219 results on '"Welsh, Sarah"'
Search Results
2. Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
3. A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
4. A combinatorial approach to uncover an additional Integrator subunit
5. The Pen and the Pan: Food, Fiction and Homegrown Caribbean Feminism(s) Cope Robyn
6. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer
7. Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
8. The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
9. Lithographically defined encoded magnetic heterostructures for the targeted screening of kidney cancer
10. Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth
11. The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol
12. Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders
13. Educating Students about the Risks of Excessive Videogame Usage.
14. Mechanism of human respiratory syncytial virus (hRSV) resistance to palivizumab
15. Common methodological pitfalls in ICI pneumonitis risk prediction studies
16. Abstract A015: Injury-associated transcriptional state transitions in early renal carcinogenesis
17. Abstract PR002: Injury-associated transcriptional state transitions in early renal carcinogenesis
18. Safety of intravenous lacosamide in critically ill children
19. Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases
20. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
21. Lithographically defined encoded magnetic heterostructures for the targeted screening of kidney cancer.
22. The role of uracil misincorporation in cell death following inhibition of thymidylate synthase
23. ‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors
24. Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle Study
25. Afterlives, Aftermaths: Levy Studies in the Twenty-First Century
26. Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8
27. Activity of Immunotherapy Regimens on Primary Renal Tumours: A Systematic Review
28. The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
29. A Randomized Ph2 Study of MEDI0680 in Combination With Durvalumab vs. Nivolumab Monotherapy in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
30. A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
31. A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
32. 'Jay Bernard’s Surge: Archival Interventions in Black British Poetry'
33. 'Reading Against the Grain: Reading The Long Song intertextually'
34. 'Not Just a Canadian Writer: 'Membering Austin Clarke'
35. Additional file 2 of The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
36. Additional file 1 of The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
37. Additional file 3 of The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
38. Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma—A Proof of Principle Study
39. Autophagic Programmed Cell Death by Selective Catalase Degradation
40. Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
41. Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma
42. Age and frailty are independently associated with increased covid-19 mortality and increased care needs in survivors: results of an international multi-centre study
43. Additional file 3 of The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer ��� a study protocol
44. Additional file 2 of The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer ��� a study protocol
45. The Integrator Complex: A Multi-Tool for Metazoan Transcription
46. Assessment of midazolam pharmacokinetics in the treatment of status epilepticus
47. The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
48. Twist, Snail, and Sox9 form an allosterically regulated complex, the EMTosome, on a bipartite E-box site
49. 'Vernacular Voices: Black British Poetry'
50. Ocular adverse events associated with immune checkpoint inhibitors: a novel multidisciplinary management algorithm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.